Tag: ANDA approval

Tentative Approval for Generics: Common Reasons for Delays

Tentative Approval for Generics: Common Reasons for Delays

Tentative approval from the FDA means a generic drug is scientifically ready - but not yet legal to sell. Common delays include patent lawsuits, manufacturing issues, and market economics that prevent launch even after approval.

Deficiency Letters in Generic Drug Applications: Common FDA Findings and How to Avoid Them

Deficiency Letters in Generic Drug Applications: Common FDA Findings and How to Avoid Them

Deficiency letters from the FDA are the most common reason generic drug applications are delayed. Learn the top 5 findings-dissolution issues, impurity controls, sameness problems-and how to avoid them to speed up approval.